BPOC has announced the sale of Midwest Products & Engineering (MPE) to Graham Partners.

MPE, founded in 1978 and based in Milwaukee, Wisconsin, is a contract designer, developer and manufacturer of electromechanical and robotic-assisted surgical systems for the medical device market.

BPOC, founded in 1996 and based in Chicago, seeks control and minority

On April 7, 2026, the U.S. Department of the Treasury’s Financial Crimes Enforcement Network (“FinCEN”) issued a Notice of Proposed Rulemaking (“NPRM”) that would formalize and, in certain respects, update the requirements for financial institutions’ anti-money laundering and countering the financing of terrorism (“AML/CFT”) programs under the Bank Secrecy Act (“BSA”).  While FinCEN has characterized the proposed rule as the centerpiece of Treasury’s broader effort to modernize the U.S. AML/CFT regulatory and supervisory framework, many of its core elements reflect longstanding statutory requirements and supervisory expectations.  The proposed rule fully supersedes a prior proposed rule FinCEN published on July 3, 2024, which the agency is withdrawing.  Concurrently, the Office of the Comptroller of the Currency (“OCC”), the Federal Deposit Insurance Corporation (“FDIC”), and the National Credit Union Administration (“NCUA”) (collectively, the “Agencies”) issued their own joint NPRM proposing substantially aligned amendments to their respective AML/CFT program rules for banks they supervise.  Public comments are due 60 days after publication in the Federal Register.

This alert summarizes the key provisions of both proposals, describes the proposed changes to bank supervision and enforcement, and identifies practical implications for financial institutions and compliance professionals.  As discussed below, many of the proposed requirements may be familiar to institutions with mature, risk-based AML/CFT programs. 

In February 2026, the Department of Health and Human Services, Office of Inspector General (HHS-OIG) issued its highly anticipated Industry Compliance Program Guidance for Medicare Advantage (MA ICPG), the first such compliance guidance for the MA industry in over 25 years. The MA ICPG is the second industry segment-specific compliance guidance published in a series

On April 1, 2026, the U.S. Court of Appeals for the Seventh Circuit, which consolidated three interlocutory appeals, issued a significant ruling in Clay v. Union Pacific Railroad Co., that resolves the question of whether Illinois’s 2024 amendment to the Biometric Information Privacy Act (“BIPA”) applies retroactively to cases pending when it was enacted.

A New Risk Landscape for AI Infrastructure

Escalating tensions involving Iran—including maritime incidents affecting oil transport and alleged cyber and physical targeting of digital infrastructure in the Middle East—highlight a growing and underappreciated risk for AI-driven data centers: disruption that originates far beyond the insured’s own operations.  These developments are not occurring in a vacuum.  They come at a time when hyperscale data center expansion has become a central driver of economic growth in the United States, as well as a national security priority, underpinning everything from cloud computing to artificial intelligence development.

Holly Buckley, Chair of Health Care at McGuireWoods, joined the Healthcare Success Podcast to share her outlook on the healthcare private equity market in 2026 ahead of the McGuireWoods annual Healthcare Private Equity and Finance Conference in Chicago (April 29-30).

On the program, she discusses why deal discipline has replaced the rapid roll-up

On Friday, April 3, 2026, the U.S. District Court for the District of Massachusetts preliminarily enjoined the Trump administration from requiring public colleges and universities in 17 states to submit seven years’ worth of Integrated Postsecondary Education Data System (IPEDS) Admission and Consumer Transparency Supplement (ACTS) survey data. The reporting deadline for the members of

The Centers for Medicare & Medicaid Services (CMS) recently released data on its 2025 settlements of voluntary self-disclosures related to past violations or potential violations of the physician self-referral law (the Stark Law). Generally, two notable items arise from our annual review of CMS’ settlement data.  First, CMS has now reported aggregate settlements reaching $105,090,031.

On March 17, 2026, the United States Court of Appeals for the Ninth Circuit issued a significant opinion in United States ex rel. Adventist Health System of West v. AbbVie Inc., [1] reversing the district court’s dismissal of a qui tam complaint brought under the False Claims Act (“FCA”) against four major drug manufacturers.